A Safety, Efficacy, and Tolerability Study of Daily Dosing With Levalbuterol Tartrate HFA MDI and Placebo in Subjects Aged Birth to less than 48 Months With Asthma.
Phase of Trial: Phase III
Latest Information Update: 10 Oct 2015
At a glance
- Drugs Levosalbutamol (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors Sunovion Pharmaceuticals
- 01 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Jun 2013 Planned End Date changed from 1 Mar 2013 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 04 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.